Publications by authors named "Defang OuYang"

Claim this Profile
F
FormulationLAI: A physiology-based machine learning framework for accelerated development of long-acting injectable formulations.
Ping Xiong, Jinying Zhu, Hao Zhong, Wei Wang, Nannan Wang, Defang Ouyang

J Control Release· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality by Computational Design: Harnessing AI to Advance Rational Drug Development.
Nannan Wang, Hao Zhong, Ping Xiong, Jinying Zhu, Defang Ouyang

Adv Drug Deliv Rev· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FormulationMM: A universal computer-driven drug formulation platform.
Yunsen Zhang, Chenyu Lin, Zhongmin Zhao, Zheng Wu, Hao Zhong, Defang Ouyang

J Control Release· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computer assisted discovery of novel nicotinamide phosphoribosyltransferase agonists to combat muscle atrophy.
Linxuan Li, Ruifeng Wang, Jianzhong Zhu, Fangqi Cao, Jingli Min, Defang Ouyang

Bioorg Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Integrated AI-PBPK Platform for Predicting Drug In Vivo Fate and Tissue Distribution in Human and Inter-Species Extrapolation.
Wei Wang, Nannan Wang, Yiyang Wu, Zhuyifan Ye, Liang Zhao, Defang Ouyang

Clin Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating artificial intelligence and physiologically based pharmacokinetic modeling to predict in vitro and in vivo fate of amorphous solid dispersions.
Jinying Zhu, Ping Xiong, Wei Wang, Tianshu Lu, Defang Ouyang

J Control Release· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the impact of interferon genes on the immune microenvironment of triple-negative breast cancer: identification of therapeutic targets.
Ying Liu, Jiayi Cai, Aamir Fahira, Kai Zhuang, Jiaojiao Wang, Defang Ouyang

Front Bioinform· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalable Artificial Polymeric Nucleases Degrading Neutrophil Extracellular Trap-DNAs and Alleviating Pulmonary Fibrosis.
Yibo Du, Chenxu Zhu, Ruifeng Wang, Shi Chen, Chuang Li, Defang OuYang

Adv Sci (Weinh)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the Optimal Dosing of Methyldopa in Pregnancy-Induced Hypertension Using PBPK-PD Modeling.
Xinyang Liu, Wei Wang, Jinying Zhu, Jingsi Chen, Xiaoyi Wang, Defang Ouyang

Clin Pharmacokinet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced antibody-mediated cellular cytotoxicity of germline-like anti-HER2 antibodies through a point mutation in complementarity-determining regions.
Guangyu Zhou, Yunsen Zhang, Yuheng Gu, Bihui Cao, Xin Fan, Defang Ouyang

J Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning-driven insights into retention mechanism in IAM chromatography of anticancer sulfonamides: Implications for biological efficacy.
Wiktor Nisterenko, Beata Żołnowska, Jiayin Deng, Dominika Zgoda, Alicja Różycka, Defang Ouyang

J Chromatogr A· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computer-driven formulation development of dipyridamole dry nanosuspension.
Tianshu Lu, Shihao Xu, Hao Zhong, Jinying Zhu, Yilu Tang, Defang Ouyang

Int J Pharm· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of in-silico approaches in subunit vaccines: Overcoming the challenges of antigen and adjuvant development.
Xue Tang, Jiayin Deng, Chunting He, Yanhua Xu, Shuting Bai, Defang Ouyang

J Control Release· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational cyclodextrin formulation design through insights into drug release mechanism in the gastrointestinal tract via molecular dynamics simulations.
Hao Zhong, Wei Wang, Ruifeng Wang, Aixin Han, Xianfeng Chen, Defang Ouyang

J Pharm Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational Approaches in Drug Delivery: Bridging Scales, Systems, and Disciplines.
Per Larsson, Defang Ouyang, Olivia Merkel

Mol Pharm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining High-Throughput Screening and Machine Learning to Predict the Formation of Both Binary and Ternary Amorphous Solid Dispersion Formulations for Early Drug Discovery and Development.
Tianshu Lu, Yiyang Wu, Ping Xiong, Hao Zhong, Yang Ding, Defang Ouyang

Pharm Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AI-directed formulation strategy design initiates rational drug development.
Nannan Wang, Jie Dong, Defang Ouyang

J Control Release· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the self-assembly and molecular structure of mRNA lipid nanoparticles at real size: Insights from the ultra-large-scale simulation.
Ruifeng Wang, Yunsen Zhang, Hao Zhong, Jieying Zang, Wei Wang, Defang Ouyang

Int J Pharm· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of excipients to the permeability of BCS class III drugs.
Shuo Wang, Dongyang Liu, Defang Ouyang

Int J Pharm· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FormulationBCS: A Machine Learning Platform Based on Diverse Molecular Representations for Biopharmaceutical Classification System (BCS) Class Prediction.
Zheng Wu, Nannan Wang, Zhuyifan Ye, Huanle Xu, Ging Chan, Defang Ouyang

Mol Pharm· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Quantitative Analysis of Physical Stability Mechanisms of Amorphous Solid Dispersions by Molecular Dynamic Simulation.
Hao Zhong, Tianshu Lu, Ruifeng Wang, Defang Ouyang

AAPS J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling patent compounds in lipid nanoparticle formulations of siRNA.
Yunfeng Han, Mengyang Wang, Yu Chen, Defang Ouyang, Ying Zheng

Mol Ther Nucleic Acids· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Analysis of Physical Stability Mechanisms of Amorphous Solid Dispersions by Molecular Dynamic Simulation.
Hao Zhong, Tianshu Lu, Ruifeng Wang, Defang Ouyang

AAPS J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing the power of machine learning into tissue engineering: current progress and future prospects.
Yiyang Wu, Xiaotong Ding, Yiwei Wang, Defang Ouyang

Burns Trauma· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery.
Wei Wang, Kepan Chen, Ting Jiang, Yiyang Wu, Zheng Wu, Defang Ouyang

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis